MedTrace Logo

Genetics of Women With Lobular Carcinoma in Situ of the Breast

NCT00536718 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2013-08-12

No results posted yet for this study

Summary

RATIONALE: Gathering information about genetic changes in patients with lobular carcinoma in situ of the breast may help doctors learn more about the disease and find better methods of treatment.

PURPOSE: This clinical trial is studying the genetics of women with lobular carcinoma in situ of the breast.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

molecular diagnostic method

GENETIC

polymorphism analysis

GENETIC

protein expression analysis

OTHER

medical chart review

OTHER

questionnaire administration

Sponsors & Collaborators

  • National Cancer Research Network

    lead NETWORK

Principal Investigators

  • Elinor Sawyer, MD · London Research Institute

  • Rebecca Roylance, MD · Barts and the London School of Medicine and Dentistry

Eligibility

Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00536718 on ClinicalTrials.gov